Outset Medical, Inc.(OM)Earnings, Financials & Key RatiosOutset Medical, Inc. (OM) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's cash position of $30.6 million is insufficient to cover ongoing quarterly net losses of $19.0 million, indicating a high risk of future dilution.
Outset Medical, Inc. (OM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Recent stock market news and headlines for Outset Medical, Inc. (OM)
Outset Medical (OM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Key metrics vs top competitors for Outset Medical, Inc. (OM)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $5.08 | $94.17M | -0.95 | 5.09% | -68.34% | -106.2% | — | |
| $235.71 | $15.13B | 24.79 | 6.46% | 5.65% | 59.11% | — | |
| $23.61 | $13B | 12.31 | 1.51% | 4.89% | 6.68% | — | |
| $2.29 | $169.22M | -0.90 | 1.48% | -87.69% | -99.78% | — | |
| $155.54 | $56.35B | 26.68 | 8.23% | 5.33% | 4.54% | — | |
| $22.58 | $11.66B | -12.90 | 5.72% | -9.7% | -16.5% | — |
Outset Medical, Inc. (OM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Outset Medical, Inc. (OM) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 7, 2026·SEC
Feb 11, 2026·SEC
Jan 27, 2026·SEC
Get notified when OM posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Outset Medical, Inc. (OM) stock FAQ — growth, dividends, profitability & financials explained
Outset Medical, Inc. (OM) reported $117.6M in revenue for fiscal year 2025. This represents a 5759% increase from $2.0M in 2018.
Outset Medical, Inc. (OM) grew revenue by 5.1% over the past year. This is steady growth.
Outset Medical, Inc. (OM) reported a net loss of $74.8M for fiscal year 2025.
Outset Medical, Inc. (OM) has a return on equity (ROE) of -106.2%. Negative ROE indicates the company is unprofitable.
Outset Medical, Inc. (OM) had negative free cash flow of $34.2M in fiscal year 2025, likely due to heavy capital investments.
